Correlation Between Tempest Therapeutics and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Tempest Therapeutics and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Rigel Pharmaceuticals.
Diversification Opportunities for Tempest Therapeutics and Rigel Pharmaceuticals
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tempest and Rigel is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Rigel Pharmaceuticals
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Tempest Therapeutics is 2.14 times less risky than Rigel Pharmaceuticals. The stock trades about -0.13 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 1,452 in Rigel Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 1,218 from holding Rigel Pharmaceuticals or generate 83.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Tempest Therapeutics |
| Rigel Pharmaceuticals |
Tempest Therapeutics and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Rigel Pharmaceuticals
The main advantage of trading using opposite Tempest Therapeutics and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals | Tempest Therapeutics vs. Seres Therapeutics |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |